$2.5M Rev, Est. In-Home Primary & Palliative Care

XYMED1U - $2.5 Million Revenue, Established In-Home Primary & Palliative Care Practice in the Midwest

Company Overview
Broker is pleased to exclusively represent a well-established, in-home primary and palliative care practice for sale in the Midwest. The Company has over a decade of operating history serving a broad patient base. It is recognized as a trusted provider of high-touch medical care for chronically ill and medically complex patients, primarily within assisted living and residential care settings.

Services
The Company provides comprehensive in-home and facility-based medical services delivered by board-certified nurse practitioners and physician assistants in collaboration with a Medical Director. Core services include chronic disease management, symptom management, transitional care following hospital or skilled nursing facility discharge, medication reconciliation and education, care coordination with primary care physicians and specialists, patient and family education, and advance care planning.

Patients & Referral Sources
The Company serves a large and stable census of over 900 active patients, with the majority of referrals originating from a well-established network of assisted living facilities. Additional referrals are generated from physician practices, home care agencies, hospice providers, and families. Referral relationships are institutional in nature and not dependent on the owner.

Payer Mix
Revenue is generated from a diversified payer base, including Medicare (40%), Medicare Advantage plans (40%), commercial insurance (10%), Medicaid (5%), and private pay (5%). All providers are credentialed with major payers in the state, supporting consistent reimbursement and limiting payer concentration risk.

Financial Highlights
Annual revenue has remained consistently around $2 million in recent years, driven primarily by recurring clinical services. In 2025, they were on pace to reach $2.5 million with over $500,000 in net income. Management expects results in 2026 will be consistent with or exceed 2025 levels.
Overall, the Company’s improved financial performance reflects durable operational improvements, a scalable provider model, and disciplined expense management, positioning the company for continued profitability and growth under new ownership.

Growth Opportunities
Significant opportunities exist for geographic expansion, increased provider capacity, deeper facility and hospital partnerships, and participation in value-based care initiatives. The Company’s established infrastructure and reputation provide a strong platform for continued growth under new ownership.

Staffing & Operations
The Company operates with an experienced multidisciplinary team of salaried clinical and administrative employees, supported by a limited number of independent contractors. The care model is well-documented and not reliant on the owner’s day-to-day involvement, supporting a smooth transition.

Exit Plan
The owner is seeking a strategic sale during a period of strong performance, positioning the business for its next phase of growth with a buyer that can further scale operations and capitalize on increasing demand for home-based and palliative care services.

Asking Price
The asking price for this opportunity is $2.25 million, which excludes cash, receivables, and working capital.